2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1346265725 M.D.
Verify on CMS →

Gazala Siddiqui, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Houston, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 621 in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
458
Medicare Part D claims · 200 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 661
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.4/100
▼ 1 pts below national avg 83.5 · Above neutral
Industry payments
$3.3K
16 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Gazala Siddiqui, M.D. reported a CMS MIPS final score of 82.4/100 - below the 83.5 national average - and filed 458 Medicare Part D claims in 2024.

82.4/100
MIPS score · -1 vs avg
458
Part D claims, 2024
66%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Gazala Siddiqui, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1346265725), first enumerated 07/13/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 458 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 82.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $3.3K in reported industry payments (16 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • State context

    State board disciplinary context

    Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Gazala Siddiqui, M.D.'s individual license status. Verify directly with the state medical board.

    Source: TMB annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1346265725 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-INLINE · RX-LIGHT · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1346265725
  • ENUM-LEGACY 2006
  • TAX-NARROW 621
  • MIPS-INLINE 82.4/100
  • RX-LIGHT 458
  • BOOK-THIN 41 in Texas
  • PHOTO-FINISH Julie Drolet · ±0.1

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Gazala Siddiqui, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

82 ≥ 36th percentile 36% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). This entry sits in this band. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Gazala Siddiqui, M.D. sits

This provider among urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician peers

Across the 201 urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Gazala Siddiqui, M.D. writes more Part D claims than 39% of them and scores higher on MIPS quality than 44% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.949.974.899.8Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 93Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 62Gazala Siddiqui, M.D., Part D claim volume, percentile in specialty: 39 · MIPS quality, percentile: 44
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one urogynecology and reconstructive pelvic surgery (obstetrics & gynecology) physician peer from a representative sample of 60; the gold marker is Gazala Siddiqui, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Gazala Siddiqui, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Gazala Siddiqui, M.D.?

Near national average

NPI registry status

Active

Issued 07/13/2006

NPI 1346265725

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

621 US NPIs in this specialty

Medicare Part D claims

458 31% vs specialty avg

2024 prescription claims

Specialty avg: 661

MIPS final score

82.4/100 1.1 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in Texas

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician6%Student in an Organized Heal…5.3%Family Nurse Practitioner4.5%Professional Counselor4.4%Pharmacist4.3%Speech-Language Pathologist3.9%Urogynecology and Reconstruc…0%
Largest specialties in Texas (% of in-state providers)

Medicare quality performance, MIPS

Gazala Siddiqui, M.D.'s 2023 MIPS final score plotted against the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician national average

Near national average
MIPS Final Score
82.4/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%82.4%
MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) - 82.4/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

6410 FANNIN ST
Houston, TX 77030

Provider Details

NPI 1346265725
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials M.D.
Gender Female
NPI Issued 07/13/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.3883
Final Score
Measured-score avg: 83.5
79.2344
Quality
58.5062
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Gazala Siddiqui, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UT Physicians
Missouri City, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Gazala Siddiqui, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$3.3K

Largest payer

Sumitomo Pharma America, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Gazala Siddiqui, M.D.. To verify Gazala Siddiqui, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Gazala Siddiqui, M.D. - brand share 34.0%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician average

34% brand-name claims vs 66% generic, on 458 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

458
Total Claims
$164K
Total Drug Cost
200
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
926.133
Total Day Supply
24,842
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$144K
Generic Drug Cost
$20K
Antibiotic Claims
110

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.26
Gender Split
100% female / 0% male
Age Distribution
<65: 14, 65-74: 96, 75-84: 70, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Gazala Siddiqui, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Estradiol
141
Myrbetriq
Mirabegron
98
Gemtesa
Vibegron
49
Cephalexin
43
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
26
Tamsulosin Hcl
22
Nitrofurantoin
Nitrofurantoin Macrocrystal
20
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
19
Mirabegron Er
Mirabegron
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How Gazala Siddiqui, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

621
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
50
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
661
Avg Claims per Provider

Gazala Siddiqui, M.D.'s 458 claims are below the specialty average of 661.

Nationwide Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Siddiqui, both outside Texas so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (82.4 here).

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Siddiqui.

One of 41 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers enrolled in Texas, 5 are shown here.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Gazala Siddiqui, M.D.'s specialty?
Gazala Siddiqui, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in Houston, Texas. Credentials: M.D..
How much does Gazala Siddiqui, M.D. prescribe under Medicare Part D?
In 2024, Gazala Siddiqui, M.D. wrote 458 Medicare Part D claims totaling $164K in drug costs for 200 beneficiaries.
What is Gazala Siddiqui, M.D.'s Medicare quality score?
Gazala Siddiqui, M.D. has a CMS MIPS Final Score of 82.4/100 (Quality: 79.2, Cost: 58.5). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Gazala Siddiqui, M.D. located?
Gazala Siddiqui, M.D. is located at 6410 FANNIN ST, Houston, TX, 77030. Phone: (832) 325-7131.
What is Gazala Siddiqui, M.D.'s NPI number?
Gazala Siddiqui, M.D.'s National Provider Identifier (NPI) is 1346265725, issued on 07/13/2006.
Does Gazala Siddiqui, M.D. prescribe more brand-name or generic drugs?
Gazala Siddiqui, M.D.'s prescribing is 34% brand-name and 66% generic drugs by claim count, with $144K in brand drug costs.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 621 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 50 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 661 Medicare Part D claims per year.
What drugs does Gazala Siddiqui, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Gazala Siddiqui, M.D.'s most frequently prescribed drugs include Estradiol, Myrbetriq, Gemtesa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Gazala Siddiqui, M.D. accept Medicare?
Gazala Siddiqui, M.D. appears in CMS Medicare data with 458 Part D claims and 200 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Gazala Siddiqui, M.D.'s credentials?
Gazala Siddiqui, M.D.'s NPI is 1346265725 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.